Skip to main content
. 2022 Oct 20;13(24):3459–3466. doi: 10.1111/1759-7714.14705

TABLE 1.

Characteristics of patients with lung cancer who were and were not diagnosed by TBB with EBUS‐GS

Diagnosed by TBB with EBUS‐GS (n = 244) Undiagnosed by TBB with EBUS‐GS (n = 123) p‐value
Age (years) 72.0 ± 9.8 72.6 ± 7.5 0.55
Sex (M/F) 162/82 73/50 0.18
Current or past smoker 177 (72.5%) 80 (65.0%) 0.14
Size (diameter, mm) 37.5 ± 17.5 30.5 ± 17.3 <0.01
Size ≥ 20 mm (diameter) 218 (89.3%) 84 (68.3%) <0.01
Bronchus sign 197 (80.7%) 44 (35.8%) <0.01
EBUS image detection 226 (92.6%) 57 (46.3%) <0.01
Pathology Adenocarcinoma 159 (65.2%) 75 (61.0%) 0.52
Squamous cell carcinoma 45 (18.4%) 29 (23.6%) 0.25
NSCLC/NOS 16 (6.6%) 2 (1.6%) <0.05
Small cell lung cancer 9 (3.7%) 4 (3.3%) 0.83
Others 15 (6.1%) 12 (9.8%) 0.21
Lobar distribution Right upper lobe 74 (30.3%) 45 (36.6%) 0.23
Right middle lobe 16 (6.6%) 7 (5.7%) 0.75
Right lower lobe 49 (20.1%) 32 (26.0%) 0.20
Left upper lobe 66 (27.0%) 24 (19.5%) 0.11
Left lower lobe 39 (16.0%) 15 (12.2%) 0.33

Abbreviations: EBUS‐GS, endobronchial ultrasonography with a guide sheath; NSCLC/NOS, non‐small cell lung cancer/not otherwise specified; TBB, transbronchial biopsy.